Despite a slower Q2, Needham sees medtech market growing 7% in 2023 (NYSE:BSX)
Despite slowed growth in Q2, the medtech sector is projected to grow by 7% in 2023, with double-digit growth in certain cardiology categories, and AtriCure, Alcon, Alphatec, Glaukos, and SI-BONE being the top-ranked companies, according to Needham.
![](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1091130498/image_1091130498.jpg?io=getty-c-w750)